ClinicalTrials.Veeva

Menu

Predictors of Mortality Among Ventilator Associated Pneumonia Patients

A

Assiut University

Status

Not yet enrolling

Conditions

Pneumonia

Study type

Observational

Funder types

Other

Identifiers

NCT06246994
Predictors of vap mortality

Details and patient eligibility

About

In this context, this study aims to explore the risk factors for mortality from VAP in respiratory ICU.

Full description

Pneumonia is the most common infection treated within ICUs and carries significant mortality risk . Ventilator-associated pneumonia (VAP) is a specific form of nosocomial pneumonia occurring in patients greater than 48 hours after intubation and the initiation of mechanical ventilation .

VAP is considered a leading cause of morbidity and mortality among intensive care unit infections. Despite various preventive measures, the incidence of VAP remains high .

In studies, VAP-related mortality is 14-70% . It is contemplated that there are independent risk factors, increasing VAP-related mortality .

However, the question of which factors are associated with early or late mortality in patients with VAP diagnosis, remains unanswered. Early identification and understanding of the etiology of VAP in the ICU is essential to prevent mortality and morbidity.

Enrollment

140 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:This study will enroll:

  1. adult participants over 18 years old who had undergone mechanical ventilation for longer than 48 hours.
  2. Only the first episode of VAP for each patient will be included.

Exclusion Criteria:

  1. Patients who are less than 18 years old.
  2. Pneumonia diagnosed before mechanical ventilation.

Trial contacts and locations

0

Loading...

Central trial contact

Marwa Kilany, Assisst- lecture; Saher Mahmoud, lecture

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems